Advanced search
Publication Cover
Cell Cycle Volume 10, 2011 - Issue 19
Submit an article Journal homepage
880
Views
26
CrossRef citations to date
0
Altmetric
Extra Views

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy

Bulbul Pandit University of Illinois at Chicago; Chicago, IL USA
&
Andrei L. Gartel University of Illinois at Chicago; Chicago, IL USACorrespondence[email protected]
Pages 3269-3273 | Received 09 Aug 2011, Accepted 12 Aug 2011, Published online: 01 Oct 2011

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ekaterina Lesovaya, Alexander Yemelyanov, Kirill Kirsanov, Alexander Popa, Gennady Belitsky, Marianna Yakubovskaya, Leo I. Gordon, Steven T. Rosen & Irina Budunova. (2013) Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies. Cell Cycle 12:1, pages 133-144.
Read now

Articles from other publishers (25)

Sanjeev Raghuwanshi & Andrei L. Gartel. (2023) Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, pages 189015.
Crossref
Woonghee Lee, Gwonhwa Song & Hyocheol Bae. (2023) Glucotropaeolin Promotes Apoptosis by Calcium Dysregulation and Attenuates Cell Migration with FOXM1 Suppression in Pancreatic Cancer Cells. Antioxidants 12:2, pages 257.
Crossref
Christian Bailly. (2022) The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications. European Journal of Pharmacology 914, pages 174661.
Crossref
Karan Ulhaka, Kanyanatt Kanokwiroon, Mattaka Khongkow, Rassanee Bissanum, Thanaporn Khunpitak & Pasarat Khongkow. (2021) The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer. International Journal of Molecular Sciences 22:13, pages 6685.
Crossref
Dhanya Kalathil, Samu John & Asha S. Nair. (2021) FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis. Frontiers in Oncology 10.
Crossref
Anastasios Kyriazoglou, Michalis Liontos, Roubini Zakopoulou, Maria Kaparelou, Anna Tsiara, Alkistis Maria Papatheodoridi, Rebecca Georgakopoulou & Flora Zagouri. (2021) The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review. Breast Care 16:1, pages 6-15.
Crossref
Cordell VanGenderen, Troy Anthony Alan Harkness & Terra Gayle Arnason. (2020) The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression. Aging 12:15, pages 15818-15855.
Crossref
Sarah Franco, Amelia Stranz, Fiona Ljumani, Go Urabe, Mirnal Chaudhary, Danielle Stewart, Vijaya Satish Pilli, Matthew Kelly, Dai Yamanouchi, K. Craig Kent & Bo Liu. (2020) Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury. Heliyon 6:6, pages e04028.
Crossref
Daniel Senfter, Mahzeiar Samadaei, Robert M. Mader, Johannes Gojo, Andreas Peyrl, Georg Krupitza, Marcel Kool, Martin Sill, Christine Haberler, Gerda Ricken, Thomas Czech, Irene Slavc & Sibylle Madlener. (2019) High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell Death & Disease 10:10.
Crossref
Philip Vlummens, Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner, Karin Vanderkerken & Ken Maes. (2019) The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma. Frontiers in Genetics 10.
Crossref
Chunyan Gu, Xuefang Jing, Carol Holman, Ramakrishna Sompallae, Fenghuang Zhan, Guido Tricot, Ye Yang & Siegfried Janz. (2018) Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer 18:1.
Crossref
Guang-zhi Dong, Ji Hye Jeong, Yu-ih Lee, Yeong Eun Han, Jung Sook Shin, Yoon-Jung Kim, Raok Jeon, Young Hwa Kim, Tae Jun Park, Keun Il Kim & Jae-Ha Ryu. (2017) A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocation. Scientific Reports 7:1.
Crossref
Lin Li, Biao Fan, Lian-Hai Zhang, Xiao-Fang Xing, Xiao-Jing Cheng, Xiao-Hong Wang, Ting Guo, Hong Du, Xian-Zi Wen & Jia-Fu Ji. (2016) Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer. Tumor Biology 37:8, pages 10269-10278.
Crossref
Marianna Halasi, Renáta Váraljai, Elizaveta Benevolenskaya & Andrei L. Gartel. (2016) A Novel Function of Molecular Chaperone HSP70. Journal of Biological Chemistry 291:1, pages 142-148.
Crossref
Andrei L. Gartel. (2014) Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors. Scientifica 2014, pages 1-5.
Crossref
MinRan Zhou, JiPing Zeng, XiaoMing Wang, Qing Guo, Tao Huang, HaiYu Shen, Yue Fu, LiXiang Wang, JiHui Jia & ChunYan Chen. (2013) MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1. Journal of Translational Medicine 11:1.
Crossref
Zhiyuan Lou, Tingting Ren, Xianbo Peng, Yifeng Sun, Guangjun Jiao, Qunshan Lu, Shuai Zhang, Xinchang Lu & Wei Guo. (2013) Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro . Journal of International Medical Research 41:5, pages 1505-1519.
Crossref
ANIRUDDHA SENGUPTA, MAHBUBUR RAHMAN, SILVIA MATEO-LOZANO, OSCAR M. TIRADO & VICENTE NOTARIO. (2013) The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing’s sarcoma. International Journal of Oncology 43:3, pages 803-812.
Crossref
Brian Cunniff, Kira Benson, Jason Stumpff, Kheng Newick, Paul Held, Douglas Taatjes, Joy Joseph, Balaraman Kalyanaraman & Nicholas H. Heintz. (2012) Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells. Journal of Cellular Physiology 228:4, pages 835-845.
Crossref
Marianna Halasi & Andrei L. Gartel. (2013) FOX(M1) News—It Is Cancer. Molecular Cancer Therapeutics 12:3, pages 245-254.
Crossref
Marianna Halasi & Andrei L. Gartel. (2013) Targeting FOXM1 in cancer. Biochemical Pharmacology 85:5, pages 644-652.
Crossref
Inken Wierstra. 2013. 191 419 .
Inken Wierstra. 2013. 97 398 .
Kheng Newick, Brian Cunniff, Kelsey Preston, Paul Held, Jack Arbiser, Harvey Pass, Brooke Mossman, Arti Shukla & Nicholas Heintz. (2012) Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells. PLoS ONE 7:6, pages e39404.
Crossref
Shuxi Qiao, Sarah D. Lamore, Christopher M. Cabello, Jessica L. Lesson, José L. Muñoz-Rodriguez & Georg T. Wondrak. (2012) Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochemical Pharmacology 83:9, pages 1229-1240.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.